AP Healthcare Inc. (KOSDAQ: 109960)

Market Cap	72.69B
Revenue (ttm)	16.66B
Net Income (ttm)	5.34B
Shares Out	114.12M
EPS (ttm)	29.79
PE Ratio	21.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	43,641
Open	644.00
Previous Close	640.00
Day's Range	630.00 - 644.00
52-Week Range	528.00 - 1,538.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About AP Healthcare

AP Healthcare Inc. distributes pharmaceutical products in South Korea. It offers prescription and over-the-counter medication, such as antibiotics, antifungal agent, antiviral drugs, infusion solution, peptic ulcer medication, osteoarthritis treatment, purifying solvent, brain function improvement agent, respiratory solvent, topical medicine, adrenocorticosteroids, urinary medicine, hair loss treatment, antipyretic analgesic and anti-inflammatory agent, antihistamines, obesity agents, neural contract, liver extract, fire extinguisher solvent, e...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1998
• Employees: 16
• Stock Exchange: KOSDAQ
• Ticker Symbol: 109960

Financial Performance

In 2023, AP Healthcare's revenue was 16.01 billion, an increase of 66.77% compared to the previous year's 9.60 billion. Earnings were 4.30 billion, an increase of 77.09%.